ES2149779T3 - Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes. - Google Patents

Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes.

Info

Publication number
ES2149779T3
ES2149779T3 ES92923745T ES92923745T ES2149779T3 ES 2149779 T3 ES2149779 T3 ES 2149779T3 ES 92923745 T ES92923745 T ES 92923745T ES 92923745 T ES92923745 T ES 92923745T ES 2149779 T3 ES2149779 T3 ES 2149779T3
Authority
ES
Spain
Prior art keywords
derived
keratinocits
listings
healing substances
pellet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92923745T
Other languages
English (en)
Inventor
Bossuyt Hans Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2149779T3 publication Critical patent/ES2149779T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO SE REFIERE A CULTIVOS DE CELULAS DE QUERATINOCITOS QUE ESTAN LIBRES DE FIBROBLASTOS NO AUTOLOGICOS, LIBRES DE EXTRACTOS ORGANICOS, PARTICULARMENTE EXTRACTOS DE PITUITARIA, Y LIBRES DE CELULAS GRANDES DE QUERATINOCITO TRANSLUCIDAS PLANAS, QUE TIENEN UNA VELOCIDAD DE REPRODUCCION CELULAR DE AL MENOS 1 DIVISION CELULAR CADA 2 DIAS.
ES92923745T 1991-11-20 1992-11-19 Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes. Expired - Lifetime ES2149779T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91403137 1991-11-20

Publications (1)

Publication Number Publication Date
ES2149779T3 true ES2149779T3 (es) 2000-11-16

Family

ID=8208640

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92923745T Expired - Lifetime ES2149779T3 (es) 1991-11-20 1992-11-19 Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes.
ES99114054T Expired - Lifetime ES2252893T3 (es) 1991-11-20 1992-11-19 Granulos derivados de queratinocitos para el uso como sustancias para la curacion de heridas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99114054T Expired - Lifetime ES2252893T3 (es) 1991-11-20 1992-11-19 Granulos derivados de queratinocitos para el uso como sustancias para la curacion de heridas.

Country Status (10)

Country Link
US (2) US6126935A (es)
EP (2) EP0970701B1 (es)
JP (1) JP3311351B2 (es)
AT (2) ATE193057T1 (es)
CA (1) CA2123683C (es)
DE (2) DE69231063T2 (es)
DK (2) DK0615545T3 (es)
ES (2) ES2149779T3 (es)
GR (1) GR3034195T3 (es)
WO (1) WO1993010217A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3377354B2 (ja) * 1995-12-25 2003-02-17 株式会社メニコン 人工皮膚
US5935850A (en) * 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US6274163B1 (en) * 1998-04-08 2001-08-14 Keraplast Technologies, Ltd. Keratinous protein material for wound healing applications and method
WO1999041364A2 (en) * 1998-02-13 1999-08-19 The Wistar Institute Compositions and methods for wound healing
WO2000073418A2 (en) * 1999-05-28 2000-12-07 Pacgen Technologies Llc A method of using autologous fibroblasts to promote healing of wounds and fistulas
US6270791B1 (en) 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
GB2369572A (en) * 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR298901A0 (en) * 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US6623733B1 (en) * 2001-06-27 2003-09-23 Advanced Cardiovascular Systems, Inc. Methods for treatment of vascular disease and device for preparation of an autologous composition for treating vascular disease
DE10151296A1 (de) 2001-10-17 2003-04-30 Boehringer Ingelheim Pharma Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
US8394371B2 (en) 2002-02-11 2013-03-12 Neocutis Sa Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
EP2047865A1 (en) 2002-12-03 2009-04-15 Celltran Limited Pharmaceutical compositions of cell lysate and processes for the production and use thereof
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
EP2329833A1 (en) * 2004-01-27 2011-06-08 The Hospital for Sick Children Research Institute Methods of making and using skin-derived stem cells
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
GB2444232A (en) * 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20090028834A1 (en) * 2007-07-27 2009-01-29 Hal Siegel Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
WO2009051622A2 (en) * 2007-10-12 2009-04-23 Immuneregen Biosciences, Inc. Methods for stimulating fibroblast proliferation using substance p analogs
PT2352472T (pt) * 2008-11-04 2017-04-11 Stratatech Corp Equivalentes de pele secos e irradiados prontos a utilizar
US20130230494A1 (en) * 2010-05-25 2013-09-05 The Research Foundation Of State University Of New York Cellular Preparations For Wound Management
CN104039953B (zh) * 2011-09-30 2016-08-17 株式会社爱茉莉太平洋 适应于角质形成细胞的黑素细胞或其祖细胞、以及其制备方法
KR101410065B1 (ko) * 2011-12-09 2014-06-27 테고사이언스 (주) 세포의 유용물질을 상온에서 안정하게 보존하는 방법
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
EP3132809A1 (en) 2015-08-21 2017-02-22 Bioskinco GmbH Composition and products comprising senescent cells for use in tissue regeneration
CN115443330A (zh) 2019-12-02 2022-12-06 奥方特蛋白质科技有限公司 使用体外细胞培养生产肉类的方法
US11306342B2 (en) 2019-12-02 2022-04-19 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US12037625B2 (en) 2021-04-09 2024-07-16 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
LU73893A1 (es) * 1975-11-28 1977-06-09
US4299819A (en) * 1979-01-02 1981-11-10 Sloan-Kettering Institute For Cancer Research Process for treating burn victims
US4254226A (en) * 1979-09-13 1981-03-03 Sloan Kettering Institute For Cancer Research Process for growing human epidermal cells in tissue culture
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US5000963A (en) * 1983-06-14 1991-03-19 Hefton John M Method of treating the skin using human epidermal sheets
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4673649A (en) * 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
DE3688168T2 (de) * 1985-08-14 1993-10-28 Memorial Hospital Cancer Epidermiszellenextrakte und Verfahren zur Verbesserung der Wundheilung und zur Regenerierung der Epidermis.
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
JPH0687301B2 (ja) * 1986-01-24 1994-11-02 富士写真フイルム株式会社 磁気記録媒体の製造方法
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US4888291A (en) * 1987-06-19 1989-12-19 President And Fellows Of Harvard College Human epithelium originating from cell cultures
IT1207525B (it) * 1987-06-23 1989-05-25 Ist Naz Ric Sul Cancro Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
JPH01256330A (ja) * 1988-04-04 1989-10-12 Zenkoku Nogyo Kyodo Kumiai Rengokai ハイブリッド稲の種子生産方法
CA2000181A1 (en) * 1988-10-14 1990-04-14 Chung-Faye Chao Process for producing cultured epidermal sheet, product and method of use
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
US5262298A (en) * 1989-05-12 1993-11-16 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
IL94611A (en) * 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
US5130142A (en) * 1990-10-31 1992-07-14 The Practer & Gamble Company Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor

Also Published As

Publication number Publication date
DE69233558D1 (de) 2005-12-01
HK1027022A1 (en) 2001-01-05
EP0970701A3 (en) 2001-12-05
ES2252893T3 (es) 2006-05-16
GR3034195T3 (en) 2000-11-30
EP0615545B1 (en) 2000-05-17
ATE193057T1 (de) 2000-06-15
DE69233558T2 (de) 2006-07-27
EP0970701A2 (en) 2000-01-12
JP3311351B2 (ja) 2002-08-05
CA2123683A1 (en) 1993-05-27
CA2123683C (en) 2007-10-30
DE69231063D1 (de) 2000-06-21
DE69231063T2 (de) 2001-01-11
EP0615545A1 (en) 1994-09-21
US5866167A (en) 1999-02-02
ATE307599T1 (de) 2005-11-15
DK0970701T3 (da) 2006-03-06
DK0615545T3 (da) 2000-10-30
JPH07501214A (ja) 1995-02-09
EP0970701B1 (en) 2005-10-26
US6126935A (en) 2000-10-03
WO1993010217A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
ES2149779T3 (es) Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes.
AU641488B2 (en) Human hematopoietic stem cell
DE60139543D1 (de) Multipotente neurale stammzellen aus hautgewebe und deren verwendungen
SI1428878T1 (sl) Postopek za proizvodnjo in čiščenje eritropoietina
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
DK295287D0 (da) Fremgangsmaade til fremstilling af ravsyre ved anaerob fermentering
ES2085245T1 (es) Procedimiento para aislar acido nucleico.
ATE447009T1 (de) Verfahren zur herstellung angereicherter hämatopoietischer zusammensetzungen, dadurch hergestellte zusammensetzungen sowie deren verwendungen
ES2077034T3 (es) Metodo de cultivo de tejidos para la transformacion de celulas vegetales.
DK0674715T4 (da) Fremgangsmåde til stabil transformation af hvede
DE69737693D1 (de) Lippenbehandlungsmittel enthaltend ein derivat von hefezellen
CO4700552A1 (es) Lineas de celulas inmortalizadas para el crecimiento de virus
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
EA200601187A1 (ru) Стволовые клетки
DE59309926D1 (de) Modul zur Züchtung und zur Nutzung der Stoffwechselleistung und/oder zum Erhalt von Mikroorganismen
DK1155116T3 (da) Anvendelse af kollagenase i fremstillingen af kulturer af neurale stamceller
EP0270615A4 (en) TRANSFORMATION AND EXPRESSION OF A FOREIGN GENE IN -i (BRASSICA) SPECIES.
ATE309267T1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
DK1235901T3 (da) Fremgangsmåde til fremstilling af celletransplantater
BE864138A (fr) Nouveaux phenyl-benzimidazolyl-furannes, leur procede de preparation et leur utilisation comme azurants optiques des matieres organiques
DE60027724D1 (de) Verbesserte keratinozytenkultur und deren verwendungen
AU5391886A (en) Method and device for the in vitro culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
ES2057462T3 (es) Extractos de cianobacterias filamentosas, su procedimiento de preparacion y actividad como factor de crecimiento.
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 615545

Country of ref document: ES